Pliant Therapeutics, Inc. filed its quarterly report on Form 10-Q with the SEC on November 12, 2026, covering the fiscal quarter ended September 30, 2026.
Andretti Acquisition Corp. II filed its Form 10-Q with the SEC on November 12, 2026, covering the quarterly period ended September 30, 2026, and reporting continued trust account activity and a significant reduction in redeemable shares outstanding.
Candel Therapeutics, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 12, 2026, covering the fiscal quarter ended September 30, 2026.
System1, Inc. filed a current report on November 12, 2026, disclosing its voluntary intention to delist its Class A Common Stock from the New York Stock Exchange and announcing financial results for the quarter ended September 30, 2026.
Hour Loop, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 12, 2026, reporting net income and year-over-year revenue growth for the nine-month period.
Flowers Foods, Inc. filed a quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 12, 2026, covering the fiscal period ended October 10, 2026.
System1, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 12, 2026, reporting a net loss of $134.4 million for the first nine months of the year alongside significant asset impairments.
Parabilis Medicines, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 12, 2026.
Evommune, Inc. (NYSE:EVMN) filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 12, 2026, disclosing condensed consolidated financial statements and related disclosures.
Streamex Corp. filed a current report on Form 8-K on November 12, 2026, announcing the availability of its financial results for the third quarter ended September 30, 2026, including an earnings release and an earnings presentation.